Kaho Momiyama

3PUBLICATIONS
4CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 27, 2026
Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial.

Gai Yamashita, Takuro Okada, Isaku Okamoto

|Nov 28, 2024
Significance of REV7 Expression in p16-Negative Oropharyngeal Squamous Cell Carcinoma.

Kaho Momiyama, Shohei Tsutsumi, Yasutaka Sakurai

Pageof 1